My Research & Publications
Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease
Peverelle M, Mills C, Testro A, Gow P, De Cruz P
Inflamm Bowel Dis. 2020 Apr 11;26(5):e35-e36. doi: 10.1093/ibd/izaa027.PMID: 32076720
Impact of Inflammatory Bowel Disease and Azathioprine on Long-Term Outcomes After Liver Transplantation for Primary Sclerosing Cholangitis
Peverelle M, De Cruz P, Paleri S, Gow PJ
Liver Transpl. 2021 May;27(5):770-771. doi: 10.1002/lt.26009
Epub 2021 Mar 19.PMID: 33569894
Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes
Peverelle M, Paleri S, Hughes J, De Cruz P, Gow PJ
Inflamm Bowel Dis. 2020 Nov 19;26(12):1901-1908. doi: 10.1093/ibd/izz325.PMID: 31944235
Ustekinumab is a Safe and Effective Biological Agent for Crohn's Disease in a Liver Transplant Patient
Peverelle M, Asadi K, De Cruz P.J
Crohns Colitis. 2020 Oct 5;14(10):1498-1499. doi: 10.1093/ecco-jcc/jjaa062.PMID: 32232397
Inducible Left Ventricular Outflow Tract Obstruction in Patients Undergoing Liver Transplantation: Prevalence, Predictors, and Association With Cardiovascular Events
Cailes B, Koshy AN, Gow P, Weinberg L, Srivastava P, Testro A, Peverelle M, Ko J, Salehi H, Jones EF, Calafiore P, Farouque O
Transplantation. 2021 Feb 1;105(2):354-362. doi: 10.1097/TP.0000000000003245.PMID: 32229775
Drug-induced liver failure due to rivaroxaban
Peverelle M, Asadi K, Sinclair M.Ann
Hematol. 2018 Nov;97(11):2267-2268. doi: 10.1007/s00277-018-3364-z
Epub 2018 May 12.PMID: 29754273
Higher long-term adherence to statins in rural patients at high atherosclerotic risk
Peverelle MR, Baradi A, Paleri S, Lee YS, Sultani R, Toukhsati SR, Hare DL, Janus E, Wilson AM.J
Clin Lipidol. 2019 Jan-Feb;13(1):163-169. doi: 10.1016/j.jacl.2018.11.004
Epub 2018 Nov 15.PMID: 30594444
Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients
Sultani R, Tong DC, Peverelle M, Lee YS, Baradi A, Wilson AM.J
Heart Lung Circ. 2020 Mar;29(3):414-421. doi: 10.1016/j.hlc.2019.03.019
Epub 2019 Apr 16.PMID: 31014557
Clinical Trial
Usefulness of Platelet-to-Lymphocyte Ratio to Predict Long-Term All-Cause Mortality in Patients at High Risk of Coronary Artery Disease Who Underwent Coronary Angiography
Lee YSG, Baradi A, Peverelle M, Sultani R, Adams H, Garlick J, Wilson AM.J
Cardiol. 2018 May 1;121(9):1021-1026. doi: 10.1016/j.amjcard.2018.01.018
Epub 2018 Feb 7.PMID: 29606325
New Names, New Drugs, Better Outcomes in Steatotic Liver Disease
Peverelle M, Mbelle M, Joshi D.Br J
Hosp Med (Lond). 2025 Aug 25;86(8):1-18. doi: 10.12968/hmed.2024.0655
Epub 2025 Aug 20.PMID: 40847981
Free article
A Rare Cause of Acute Gastrointestinal Haemorrhage: Bleeding Gastric Diverticulum
Peverelle M, Reynauld B.J
Gastrointestin Liver Dis. 2025 Jun 28;34(2):151. doi: 10.15403/jgld-5847.PMID: 40580543
Free article
Endoscopy volume and outcomes after the COVID-19 pandemic: results from a tertiary Australian centre
Peverelle M, Hirsch R, Slifirski W, Ea V, Sun G, Sane N, Nguyen A, Erceg D, Wang A, Tucker S, Koh E, Long T, Hew S
Intern Med J. 2025 Feb;55(2):337-338. doi: 10.1111/imj.16642.PMID: 39937434
Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis
Peverelle M, Ng J, Peverelle J, Hirsch RD, Testro A
World J Gastroenterol. 2023 Dec 21;29(47):6165-6167. doi: 10.3748/wjg.v29.i47.6165.PMID: 38186682
Free PMC article